Vertex Pharma Officer Files to Sell $1.05M in Stock Under Plan
VERTEX PHARMACEUTICALS INC / MA
Subscribe to track VRTX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Vertex Pharma Officer Files to Sell $1.05M in Stock Under Plan
Company: VERTEX PHARMACEUTICALS INC / MA Form: 144 | Filed: 2026/03/27 Significance: Low
Insider: Bozic Carmen Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 2,329 • Price: ~$450.95 (Est.) • Value: $1,050,262.55
Key Insight: Routine sale of shares acquired via Restricted Stock Vesting. Executed under a 10b5-1 plan adopted in Nov 2025. Represents <0.001% of market cap.
Market Context: Transaction is negligible relative to $119B market cap. Part of a consistent selling pattern (similar sales in Feb/Mar).
Comprehensive Analysis
SEC Filing Analysis: VERTEX PHARMACEUTICALS INC / MA
Executive Summary
- Trading Significance: Low
- Key Takeaway: Routine sale of vested restricted stock under a pre-arranged 10b5-1 trading plan.
- Market Impact: Negligible; transaction represents less than 0.001% of market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | VERTEX PHARMACEUTICALS INC / MA |
| CIK | 0000875320 |
| Industry | Pharmaceutical Preparations |
| Market Cap | $119.23 Billion |
Insider Information
| Field | Value |
|---|---|
| Name | Bozic Carmen |
| CIK | 0001790029 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 (Notice of Proposed Sale) |
| Approx. Sale Date | 03/27/2026 |
| Transaction Code | S (Proposed) |
| Security Type | Common Stock |
| Shares Involved | 2,329 |
| Price Per Share | ~$450.95 (Calculated) |
| Total Value | $1,050,262.55 |
| Source of Shares | Restricted Stock Vesting |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,050,262.55 |
| % of Market Cap | 0.00088% |
| Shares Transacted | 2,329 |
| % of Shares Outstanding | 0.00092% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a Large Cap company ($119B), a $1M transaction is routine and immaterial to the stock price.
- Transaction Significance: The transaction represents a microscopic fraction of the company's value and float. It does not signal a shift in insider sentiment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is small, automated (10b5-1 plan), and related to compensation vesting. It will have no mechanical impact on the stock price.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral. The sale is consistent with tax-covering behavior for vested equity.
Additional Context
Transaction Notes
- 10b5-1 Plan: Yes, adopted on 11/20/2025. This indicates the sale was pre-planned and not based on current material non-public information.
- Pattern: The filer has executed identical sales of 2,329 shares on 02/27/2026 and 03/13/2026, confirming a systematic liquidation pattern likely tied to vesting schedules.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.